20 results
Early Events in Acute GVHD #Pathophys #Honc #GVHD #GraftVersusHostDisease #NEJM
Events in Acute GVHD ... #Pathophys #Honc ... #GVHD #GraftVersusHostDisease
Biologic Events Leading to Chronic GVHD #Pathophys #Honc #Pharm #GVHD #GraftVersusHostDisease #Therapeutic #Pathways #NEJM
Leading to Chronic GVHD ... #Pathophys #Honc ... #Pharm #GVHD #GraftVersusHostDisease
Algorithm for the Evaluation of Anemia #Diagnosis #EM #IM #Honc #Anemia #Differential #Workup #Algorithm #Microcytic #Macrocytic
Anemia #Diagnosis #EM ... #IM #Honc #Anemia
Evaluation of Lymphadenopathy - Localized vs Generalized #Diagnosis #EM #IM #Honc #Lymphadenopathy #Localized #Generalized #Infectious #Malignancy
Generalized #Diagnosis #EM ... #IM #Honc #Lymphadenopathy
Differential Diagnosis of Anemias #Diagnosis #IM #Honc #Anemia #Differential #Iron #Algorithm #Microcytic #Macrocytic #Normocytic #Ddxof
Anemias #Diagnosis #IM ... #Honc #Anemia #
An AAV5 vector with a functional factor VIII gene tested in men with hemophilia A #EBM
hemophilia A #EBM ... #Honc #hemophilia
Immunosuppressive Strategies for the Prevention or Treatment of Acute GVHD. Panel A shows several classic immunosuppressive
Treatment of Acute GVHD ... preclinical models of GVHD ... to reduce acute GVHD ... Pathophysiology #IM ... #Honc #Pharm #GVHD
Clinical and Histopathological Findings in Chronic Graft-versus-Host Disease (GVHD). #Clinical #Honc #GVHD #GraftVersusHostDisease #NEJM
Graft-versus-Host Disease (GVHD ... #Clinical #Honc ... #GVHD #GraftVersusHostDisease
Progression-free Survival  #EBM #Honc #Osimertinib #NSCLC #Survival #NEJM
Progression-free Survival #EBM ... #Honc #Osimertinib
CRAB Criteria Used in the Diagnosis of Multiple Myeloma #Diagnosis #IM #Honc #CRAB #MultipleMyeloma #MM
Myeloma #Diagnosis #IM ... #Honc #CRAB #MultipleMyeloma